Synlogic Inc To Announces Proof of Concept for SYNB8802 in Enteric Hyperoxaluria call Transcript
Welcome to the Conference Call for Synlogic's Proof of Concept Data for SYNB8802 for Enteric Hyperoxaluria. (Operator Instructions)
I would now like to turn the call over to Andrew Funderburk of Kendall Investor Relations.
Thank you, operator. Good morning, and thank you for joining us on today's conference call. This morning, we issued a press release, which announced our proof of concept data for SYNB8802 in enteric hyperoxaluria. The release is available on the Investors section of our website at www.synlogictx.com.
As we begin, I'd like to remind everyone that comments today may include forward-looking statements made under the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made as of the date hereof and are subject to numerous factors, assumptions, risks and uncertainties, which change over time. Actual results could differ materially from those contained in any forward-looking statements as a result of various factors,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
